Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRIT-LC
ChiCTR-OIN-16008205Phase 2Recruiting
- Sponsor
- Beidahuang Group General Hospital
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in Pulmonary squamous cell carcinoma, sponsored by Beidahuang Group General Hospital. Primary endpoint: Progression-free survival. Started Apr 2016; status: recruiting.
02
Drugs
tegafur
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR-OIN-16008205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16008205.